Between 1954 and 1988 only a total of twenty five cases of primary adenocarcinoma of the small bowel (excluding periampillary tumours) were recorded at the
Primary adenocarcinomas of the small intestine are rare. Although the small bowel accounts for about three quarters of the length of gastrointestinal tract, malignant tumours of the small intestine only account for 1 Duodenal and periampullary carcinomas differ clinically from jejunal and ileal carcinomas. Periampullary tumours may also arise from the bile duct or pancreatic ducts. We therefore did not include these tumours in this study but we did include tumours arising in the duodeno-jejunal flexure.
The rarity of these tumours combined with non-specific signs and symptoms can delay prompt diagnosis and treatment. Furthermore, their inaccessibility by endoscopic instruments and the limitations of radiographic techniques hinder their early detection.
Methods
Twenty six cases of primary adenocarcinoma of the small intestine, excluding duodenal and periampullary tumours, were retrieved from our files at the Belfast City Hospital between 1954 and 1988. The charts of 19 of the cases were available for study, although all the slides were reviewed. The duration of signs and symptoms, treatment, and clinical outcome were noted. The site of the tumour was checked with the surgical notes.
The mucosal origin of the tumour was sought. One tumour was excluded when the mucosal origin could not be established and the poorly differentiated tumour cells stained negatively for epithelial markers by the immunoperoxidase technique. The tumours were graded according to differentiation: grade 1 = well, grade 2 = moderately, and grade 3 = poorly differentiated (figs la-c), depending on the degree of glandular formation and nuclear characteristics.
Well differentiated adenocarcinoma showed well formed tubules and nuclei of uniform size and shape. Whether or not crowding and stratification were evident in the nuclei the polarity was well maintained. Poorly differentiated tumours had irregular tubular structures or none at all, and tumour cells were arranged in sheets, cords, or clumps. Other associated pathological features such as an extensive mucoid component of the tumour and adjacent mucosal atrophy were also noted.
Results
Sixteen of the 25 cases were female, giving a female:male ratio of 1 7:1. All of the patients were Caucasian. Their ages at the time of (table 2) . In six of the cases, five jejunal and one ileal, the adenocarcinoma could be seen arising from a pre-existing villous adenoma (fig 2) , and in four, two cases of each, the tumour had a large mucoid component. In two of the jejunal tumours the adjacent small bowel mucosa for some distance away from the neoplastic growth, showed evidence of subtotal villous atrophy associated with crypt hyperplasia and an increase in chronic inflammatory cell infiltrate in the lamina propria, features which are suggestive of coeliac disease (fig 3) .
OTHER ASSOCIATED FINDINGS
It has been well recognised and reported by various authors that there is a higher incidence of adenocarcinoma of the small bowel in patients with Crohn's disease, and in our series one of the tumours in the terminal ileum also had features of Crohn's disease in the adjacent bowel mucosa and wall. Concurrent neoplasms were present in three cases: one case of adenocarcinoma of the terminal ileum had a Meckel's diverticulum and carcinoid tumour; another case of terminal ileum tumour had a second primary adenocarcinoma of the colon; and a third case of ileal tumour had a colonic adenoma. Primary adenocarcinoma of the jejunum and ileum They also found that adenoma affecting the ampulla contained carcinoma more often than lesions found elsewhere in the duodenum and small intestine.
Although T cell lymphomas are known to arise in the jejunal mucosa of patients with coeliac disease, there is also an uncommon association with adenocarcinoma in these patients.'5 Of our 14 jejunal carcinomas, we noted in two that the adjacent small bowel mucosa distal from the main tumour mass showed features in keeping with coeliac disease. Although one of the patients also had a history of weight loss, neither was investigated for malabsorption, nor had coeliac disease been diagnosed before the discovery of the tumours.
Bridge et al reported two jejunal adenocarcinomas associated with mucosal atrophy in their series of 43 cases.7 Holmes et al described four patients with long histories of coeliac disease, three of whom were confirmed by jejunal biopsy and later progressed-to develop an adenocarcinoma of the jejunum.9 In one of the adenocarcinomas of the terminal ileum in our series there was concomitant Crohn's dis- Barclay et al reported a high incidence (20 3°0 ) ofpatients with adenocarcinoma of the small bowel who had a second primary cancer in other sites.5 This was not borne out in our study; in only two of our 25 (8%) cases was there a second primary tumour (one carcinoid of the ileum and one carcinoma of the colon).
Adenocarcinoma of the small bowel carries an appalling prognosis. In just over half of our cases nodal disease and distant metastases were present at the time of diagnosis which usually followed a laparotomy. Only three of our 19 cases with known clinical outcome and follow up survived more than five years, giving a five year survival of 1570,. Other studies have reported a five year survival ranging from 0-280e2 In this series the most important prognostic factor was the depth of tumour invasion or stage at the time of diagnosis. In all three survivors in our series the tumours were located at the duodeno-jejunal flexure in one, and jejunum in the other two. We found that on average, jejunal carcinomas had a smaller size, compared with ileal tumours. This was also noted by Bridge et al. 7 Perhaps patients with tumours at this site present earlier with shorter duration of symptoms. This was seen in two of the survivors who had had symptoms of four weeks duration (average in the series was nine weeks), but the other patient, however, had symptoms for six to eight months. There did not seem to be any correlation between the duration or group of symptoms and the actual site of tumour formation.
In two of the survivors the tumour was graded 3, while the other was well differentiated or grade 1. Although in one of the grade 3 survivors nodal disease was established in the resected specimen, remarkably, there was no evidence of tumour recurrence even after five years. Overall, however, the tumour size and grade did not seem to correlate well with survival.
Most patients presented with features of intestinal obstruction, with epigastric pain being the most common complaint, usually associated with nausea and vomiting, weight loss, and some change in bowel habit. In two female patients a cholecystectomy was performed and the persistence of symptoms eventually led to the diagnosis of small bowel tumour. These non-specific symptoms and signs, combined with the inaccessibility of the small bowel by endoscopic instruments, often led to late diagnosis of these neoplasms. The rarity of these tumours coupled with a low index of suspicion by the clinician also hinder prompt diagnosis and lead to high mortality.
All of our patients were treated by surgical resection which seemed to be the only effective treatment. None received any adjuvant chemotherapy or radiotherapy. In the series reported by Hag et al 9 and Morgan et al2 some of their patients were given postoperative chemotherapy in the form of 5-fluorouracil, cyclophosphamide, vincristine and methyl CCNU, or a combination, but this did not seem to increase their chance of survival.
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